Late Pregnancy · Liver
ICP (Obstetric Cholestasis) — Itchy Palms + Bile Acids
Severe itching of palms + soles in late pregnancy (no rash) = potentially ICP. Bile acid blood test confirms. Urso treatment + planned delivery 35-38 weeks based on severity. Stillbirth risk rises sharply if bile acids ≥100 µmol/L (Ovadia 2019). RCOG Green-top 43.
Last reviewed 2 June 2026
Bile-acid-stratified delivery timing
Troubleshooting + common pitfalls
- Pitfall: Treating any pruritus as ICP.
Solution: Bile acids confirm. Pregnancy pruritus is common (~20 %); ICP affects ~0.7 %. Polymorphic eruption of pregnancy (PEP), pemphigoid gestationis, eczema, scabies are differentials. Persistent palm/sole pruritus without rash & worse at night is classical for ICP. - Pitfall: Using ALT instead of bile acids for severity.
Solution: Bile acids are the diagnostic and severity marker; ALT is supportive but not the stratifier. Ovadia 2019 IPD-MA identified the ≥ 100 µmol/L bile-acid threshold for stillbirth risk; ALT doesn’t correlate with stillbirth as cleanly. - Pitfall: Reassuring with normal CTG in severe ICP.
Solution: Stillbirth in ICP is SUDDEN — CTG / BPP / Doppler do NOT predict it. Don’t use surveillance reassurance to defer delivery past 36 wk in severe ICP. - Pitfall: Withholding UDCA because PITCHES was negative for stillbirth.
Solution: PITCHES (Lancet 2019) showed UDCA didn’t reduce stillbirth, BUT it improves maternal itch and biochemistry. Continue using for symptom control; just don’t let it falsely reassure about fetal risk. - Pitfall: Random (non-fasting) vs fasting bile acid confusion.
Solution: RCOG 2022 uses NON-FASTING (random) total bile acids; fasting was previously standard but doesn’t change diagnosis or severity bands. Use whichever your lab reports consistently. - Pitfall: Missing alternative cause of cholestasis.
Solution: If bile acids > 200 μmol/L, very early onset (< 24 wk), persistent post-delivery, severe transaminitis (> 1000), jaundice, or family history — investigate Wilson’s, viral hepatitis, autoimmune, biliary obstruction, drug-induced cholestasis. - Pitfall: Vitamin K forgotten in severe ICP.
Solution: Severe ICP can cause vitamin-K-dependent coagulopathy. Check PT; replace 10 mg PO daily if prolonged. Neonate also gets standard IM vitamin K at birth. - Pitfall: Not warning about recurrence.
Solution: 60–90 % recurrence in subsequent pregnancies. Combined hormonal contraception postpartum can also cause pruritus / cholestasis in some women. - Pitfall: Delivering everyone at 35 wk regardless of severity.
Solution: Stratify by bile acids. Severe (≥ 100) → 35–36 wk. Moderate (40–99) → 38–39 wk. Mild (< 40) → 39–40 wk. Iatrogenic prematurity in mild ICP causes more harm than the stillbirth risk it’s trying to prevent. - Pitfall: Persisting symptoms postpartum dismissed.
Solution: ICP should resolve completely within 4–6 weeks postpartum — if itch / biochemistry persist, investigate other liver disease. - Pitfall: Forgetting maternal mental health.
Solution: Sleep-deprivation from nocturnal itch is severe in ICP. Mental health, sleep hygiene, antihistamine for night use, cool baths. - Pitfall: Aspirin or NSAIDs in jaundiced ICP.
Solution: Avoid NSAIDs; aspirin OK if PE indication.
What is ICP?
Intrahepatic Cholestasis of Pregnancy (ICP)— pregnancy-specific liver condition where bile acids build up in the blood. The bile acids in your skin cause intense itching.
Usually palms + soles first; can spread. Worse at night. NO rash (just scratch marks).
Affects ~1 in 140 pregnancies UK; higher in South Asian / Scandinavian / Hispanic women, family history. Resolves within days-weeks after birth.
Itchy palms = same-day blood test
UK NHS: itchy palms / soles in pregnancy + no rash should prompt SAME-DAY blood test for ICP. Don’t wait.
Blood test is cheap + quick: bile acids + liver enzymes (ALT).
Diagnosis
- Total bile acids (random / non-fasting) >10 µmol/L = diagnostic.
- ALT, GGT may also be raised.
- Itching + bile acids >10 = ICP confirmed.
Screen for other causes if: very early onset (<24 weeks); bile acids >200; jaundice; very raised liver enzymes; family history of liver disease.
Stillbirth risk by bile acid level
Ovadia 2019 Lancet meta-analysis (5,557 women):
- <40 µmol/L: ~background risk.
- 40-99 µmol/L: slightly raised, mainly from 35+ weeks.
- ≥100 µmol/L: sharply raised from 35 weeks onward (~3% if untreated).
Risk manageable with appropriate care. Most babies born to ICP mothers: healthy.
Treatment
- Ursodeoxycholic acid (Urso, UDCA) — first-line; 500-1500 mg/day; safe in pregnancy + breastfeeding.
- Antihistamines — chlorphenamine (Piriton) at night for sleep.
- Cool baths, cold compresses, calamine lotion.
- Weekly blood tests for bile acids + LFTs.
Delivery timing
- Mild (bile acids 10-39): 39-40 weeks.
- Moderate (40-99): 37-38 weeks.
- Severe (≥100): 35-37 weeks.
Induction usually offered. Continuous CTG in labour. Antenatal steroids if delivery before 36 weeks.
Will Urso work?
Evidence mixed. Helps ITCH and liver enzymes. PITCHES trial 2019 showed no clear stillbirth reduction; later subgroup analyses suggested benefit. UK / RCOG standard treatment.
Most women report symptom improvement within days-week. Safe in pregnancy + breastfeeding.
Coping with severe itch
- Cool temperatures — AC, fan, cold bedroom.
- Cool baths with oatmeal or sodium bicarbonate.
- Cold compresses / ice packs on palms / soles.
- Cotton gloves at night to prevent scratching damage.
- Distraction — TV, audiobooks.
- Antihistamines at bedtime.
- Gentle moisturiser (avoid perfumed).
- Mental health support — sleep deprivation real.
Next pregnancy
~70-80% recurrence. Preconception discussion with GP; bile acid testing from 24-26 weeks if symptoms. Plan more intensive monitoring. Not your fault — genetic predisposition.
Different scenarios — ICP
Scenario 1: 32 weeks, severe itchy palms + soles, no rash
Same-day bloods. If bile acids >10 = ICP. Urso. Weekly monitoring. Delivery plan based on peak.
Scenario 2: Bile acids 35, otherwise mild ICP
Urso. Weekly bloods. Delivery 39-40 weeks. Usually uncomplicated.
Scenario 3: Bile acids 150 at 34 weeks
Severe. Steroids for baby’s lungs. Delivery 35-37 weeks planned. Continuous monitoring. NICU briefing.
Scenario 4: Previous ICP, this pregnancy 24 weeks, itching starting
Known recurrence pattern. Bloods early. If positive, start Urso. Intensive monitoring. May develop earlier delivery plan.
Scenario 5: Itchy palms + jaundice (yellow eyes), 20 weeks
Atypical — very early onset + jaundice = workup beyond standard ICP. Hepatitis screen, autoimmune, biliary obstruction. Specialist hepatology + obstetric input.
Care guidance — ICP
- Same-day bloods for any itchy palms / soles in pregnancy.
- Weekly monitoring if diagnosed.
- Urso first-line treatment.
- Antihistamines for sleep.
- Cool environment + cold compresses.
- Planned delivery by severity.
- Steroids if preterm.
- Continuous CTG in labour.
- Postpartum: itching resolves within days-weeks.
- Next pregnancy: recurrence ~70-80%; plan early.
- Support: ICP Support charity (UK), Sands.
Sources
- RCOG Green-top Guideline 43. Obstetric cholestasis (2022 update).
- Ovadia C, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019.
- Chappell LC, et al. PITCHES trial: ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy. Lancet 2019.
- ICP Support (UK charity). icpsupport.org.
Recommended for this calculator